The first large population-based study to evaluate erectile dysfunction (ED) and premature ejaculation (PE) in Poland. The study objective is to assess the prevalence and bother of ED and PE in the representative group of male population of Poland.
Study Type
OBSERVATIONAL
Enrollment
3,000
Participants will be asked to complete validated questionnaires (the five-item International Index of Erectile Function - IIEF-5, Premature Ejaculation Diagnostic Tool - PEDT, International Prostate Symptom Score - IPSS, Overactive Bladder - Validated 8-question Screener - OAB-V8, Hospital Anxiety and Depression Scale - HADS, Athens Insomnia Scale - AIS).
Department of Urology, Jagiellonian University
Krakow, Lesser Poland Voivodeship, Poland
Prevalence of ED in Poland
The prevalence of ED will be assessed using the five-item International Index of Erectile Function (IIEF-5; the lowest score 5; the highest score 25; the lower the score, the greater the severity of the symptoms)
Time frame: Through study completion, an average of 3 months
Prevalence of PE in Poland
The prevalence of PE will be assessed using the Premature Ejaculation Diagnostic Tool (PEDT; the lowest score 0; the highest score 20; the lower the score, the lower the severity of the symptoms)
Time frame: Through study completion, an average of 3 months
Bother of ED and PE in Poland
The degree of associated bother will be assessed using Likert scale (Likert scale: delighted \[score 0\], pleased \[score 1\], mostly satisfied \[score 2\], mixed \[score 3\], mostly dissatisfied \[score 4\], unhappy \[score 5\], or terrible \[score 6\]).
Time frame: Through study completion, an average of 3 months
Prevalence of lower urinary tract symptoms in patients with PE and ED in Poland
The prevalence of lower urinary tract symptoms will be assessed with the International Prostate Symptom Score (IPSS; the lowest score 0, the highest score 35, the lower the score, the lower the severity of the symptoms)
Time frame: Through study completion, an average of 3 months
Prevalence of overactive bladder in patients with PE and ED in Poland
The prevalence of overactive bladder will be assessed with the Overactive Bladder - Validated 8-question Screener (OAB-V8; the lowest score 0; the highest score 40; the lower the score, the lower the severity of the symptoms)
Time frame: Through study completion, an average of 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Prevalence of depressive symptoms in patients with PE and ED in Poland
The prevalence of depressive symptoms will be assessed with the Hospital Anxiety and Depression Scale (HADS; the lowest score 0; the highest score 48; the lower the score, the lower the severity of the symptoms)
Time frame: Through study completion, an average of 3 months
Prevalence of insomnia in patients with PE and ED in Poland
The prevalence of insomnia will be assessed with the Athens Insomnia Scale (AIS; the lowest score 0; the highest score 24; the lower the score, the lower the severity of the symptoms)
Time frame: Through study completion, an average of 3 months